Comerica Bank
VIR icon

Comerica Bank’s Vir Biotechnology VIR Stock Holding History

Comerica Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$128K Sell
21,238
-1,835
-8% -$10.9K ﹤0.01% 2527
2025
Q3 		$132K Sell
23,073
-3,709
-14% -$19K ﹤0.01% 2503
2025
Q2 		$135K Sell
26,782
-532
-2% -$2.85K ﹤0.01% 2494
2025
Q1 		$177K Sell
27,314
-441
-2% -$3.92K ﹤0.01% 2356
2024
Q4 		$204K Buy
27,755
+208
+0.8% +$1.64K ﹤0.01% 2303
2024
Q3 		$206K Sell
27,547
-400
-1% -$3.47K ﹤0.01% 2284
2024
Q2 		$249K Sell
27,947
-4,545
-14% -$43.6K ﹤0.01% 2169
2024
Q1 		$329K Sell
32,492
-2,990
-8% -$30.5K ﹤0.01% 2076
2023
Q4 		$357K Buy
35,482
+920
+3% +$8.41K ﹤0.01% 2020
2023
Q3 		$324K Buy
+34,562
New +$493K ﹤0.01% 1999
2022
Q4 		$1.1M Sell
42,035
-12,535
-23% -$307K 0.01% 1388
2022
Q3 		$1.19M Sell
54,570
-5,405
-9% -$137K 0.01% 1376
2022
Q2 		$1.76M Buy
+59,975
New +$1.4M 0.01% 1186

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Comerica Bank's VIR Position: Q4 2025 in Review

Comerica Bank reduced its Vir Biotechnology (VIR) stake by 8% in Q4 2025, selling an estimated $10.9K and leaving 21,238 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Comerica Bank first reported a position in VIR in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.76M in Q2 2022. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Comerica Bank held 21,238 shares of Vir Biotechnology worth $128K as of Q4 2025.
  • Comerica Bank sold 1,835 Vir Biotechnology shares in Q4 2025, an estimated $10.9K.
  • Vir Biotechnology made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2527 holding.
  • Comerica Bank first reported a position in Vir Biotechnology in Q2 2022 and has held it in 13 quarters since.
  • Comerica Bank's Vir Biotechnology position peaked at $1.76M in Q2 2022.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.